A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma.
about
Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular CarcinomaReprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospectsInvestigational cancer drugs targeting cell metabolism in clinical development.Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.Anticancer agents interacting with membrane glucose transporters.Inducers of Senescence, Toxic Compounds, and Senolytics: The Multiple Faces of Nrf2-Activating Phytochemicals in Cancer Adjuvant Therapy.
P2860
A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase I dose-finding study o ...... nced hepatocellular carcinoma.
@en
A phase I dose-finding study of silybin phosphatidylcholine
@nl
type
label
A phase I dose-finding study o ...... nced hepatocellular carcinoma.
@en
A phase I dose-finding study of silybin phosphatidylcholine
@nl
prefLabel
A phase I dose-finding study o ...... nced hepatocellular carcinoma.
@en
A phase I dose-finding study of silybin phosphatidylcholine
@nl
P2093
P2860
P356
P1476
A phase I dose-finding study o ...... nced hepatocellular carcinoma.
@en
P2093
Abby B Siegel
Abhishek Goyal
Daniel L Gustafson
David P H Wu
Elena Ladas
Heather Greenlee
Judith S Jacobson
Kara Kelly
Paul J Lunghofer
Rosa Rodriguez
P2860
P356
10.1177/1534735413490798
P577
2013-06-11T00:00:00Z